- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
American College of Cardiology
Coverage of the latest and most impactful data from the American College of Cardiology's 70th Scientific Sessions. A virtual experience, ACC.21 is scheduled to be held from May 15-17 and feature more than 3000 pieces of data. Coverage of the event will include articles on late-breaking data, video interviews with leading experts, and more.
DCT Demonstrates Ability of Digital Programs to Improve Care, Blood Pressure Management
May 21, 2021
An analysis of patients who achieved blood pressure goal within a digital care program details the potential ability of digital health interventions to improve management of patients with hypertension.
New Strategies Needed to Address Cardiovascular Risk Trajectory Associated with Prediabetes
May 20, 2021
Analysis of the UK Biobank cohort details a graded increase in risk of cardiovascular and renal events across the glycemic spectrum, including among patients with prediabetes.
Analysis Details SGLT2 Inhibitors Benefit Across Heart Failure Subgroups
May 20, 2021
Hear from Deepak Bhatt, MD, MPH, on a systematic review and meta-analysis of SGLT2 inhibitor trials examining the effects of the class on heart failure across multiple subgroups, including those with preserved ejection fraction.
ACC.21 Top Data Summary
May 19, 2021
Our editorial staff and advisory board have teamed up to provide you with a shortlist of highlighted data and summary slides on their picks for the most important data to be released at the American College of Cardiology's 70th Annual Scientific Session.
Dissonance Between Clinicians and Patients Could Prevent Optimal Prescription of Oral Anticoagulants
May 19, 2021
An analysis of patient and clinician responses to surveys within BOAT-AF suggests many were willing to consider DOACs but were never prescribed anticoagulation and also provides insight into how trends in this cohort compared to those in the ACC's PINNACLE registry.
ACC.21 Simulation Study Estimates CV Event Risk Reduction with Bempedoic Acid
May 19, 2021
A pooled risk simulation of phase 3 data of bempedoic acid suggests the first-in-class ATP citrate lyase inhibitor could reduce risk of cardiovascular events in patients with established cardiovascular disease and elevated LDL-C.
RADIANCE-HTN TRIO Supports Use of Renal Denervation in Refractory Hypertension
May 18, 2021
Results of RADIANCE-HTN TRIO suggest ultrasound renal denervation could improve blood pressure control in patients with refractory hypertension, suggesting RDN was associated with a mean reduction of 8 mmHg from baseline a 4.5 mmHg improvement over sham procedure.
Mavacamten Could Contribute to Improved Health Status in Obstructive Hypertrophic Cardiomyopathy
May 18, 2021
New data from an ACC.21 analysis suggests apparent improvements in patient symptoms, function, and quality of life seen on mavacamten were not sustained once treatment was discontinued.
FIDELIO-DKD Analysis Finds Finerenone Reduces Risk of New-Onset AFib
May 17, 2021
An analysis of FIDELIO-DKD indicates use of finerenone was associated with significant reductions in risk of new-onset atrial fibrillation in patients with type 2 diabetes and chronic kidney disease.
COVID-19 Has Increased Burnout, Desire for Career Change in Cardiology
May 17, 2021
Results of a well-being study presented at ACC.21 paint a grim picture related to the impact of COVID-19 on burnout and well-being among cardiology professionals. We sat down with lead investigator Laxmi Mehta, MD, for further perspective on the issue.